journal
MENU ▼
Read by QxMD icon Read
search

Clinical Genitourinary Cancer

journal
https://www.readbyqxmd.com/read/28528087/prognostic-value-of-inflammatory-and-nutritional-scores-in-renal-cell-carcinoma-after-nephrectomy
#1
Ding Peng, Zhi-Song He, Xue-Song Li, Qi Tang, Lei Zhang, Kai-Wei Yang, Xiao-Teng Yu, Cui-Jian Zhang, Li-Qun Zhou
INTRODUCTION: We compared the prognostic significance of inflammatory and nutritional scores, including the prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in patients with renal cell carcinoma (RCC) undergoing nephrectomy. PATIENTS AND METHODS: We retrospectively analyzed the data from 1360 patients with RCC undergoing nephrectomy from 2001 to 2010. The PNI was calculated as the serum albumin level (g/L) + 5 × lymphocyte count (10(9)/L)...
April 27, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28550955/effect-of-hospital-and-surgeon-case-volume-on-perioperative-quality-of-care-and-short-term-outcomes-after-radical-cystectomy-for-muscle-invasive-bladder-cancer-results-from-a-european-tertiary-care-center-cohort
#2
Malte W Vetterlein, Christian P Meyer, Sami-Ramzi Leyh-Bannurah, Roman Mayr, Michael Gierth, Hans-Martin Fritsche, Maximilian Burger, Bastian Keck, Bernd Wullich, Thomas Martini, Christian Bolenz, Armin Pycha, Julian Hanske, Florian Roghmann, Joachim Noldus, Patrick J Bastian, Christian Gilfrich, Matthias May, Michael Rink, Felix K-H Chun, Roland Dahlem, Margit Fisch, Atiqullah Aziz
BACKGROUND: Case volume has been suggested to affect surgical outcomes in different arrays of procedures. We aimed to delineate the relationship between case volume and surgical outcomes and quality of care criteria of radical cystectomy (RC) in a prospectively collected multicenter cohort. PATIENTS AND METHODS: This was a retrospective analysis of a prospectively collected European cohort of patients with bladder cancer treated with RC in 2011. We relied on 479 and 459 eligible patients with available information on hospital case volume and surgeon case volume, respectively...
April 26, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28549862/clinicopathologic-characteristics-and-prognosis-of-xp11-2-translocation-renal-cell-carcinoma-multicenter-propensity-score-matching-analysis
#3
Min Soo Choo, Chang Wook Jeong, Cheryn Song, Hwang Gyun Jeon, Seong Il Seo, Sung Kyu Hong, Seok-Soo Byun, Jin Soo Chung, Sung-Hoo Hong, Eu Chang Hwang, Hyeon Hoe Kim, Cheol Kwak
BACKGROUND: We evaluated the clinicopathologic characteristics and prognosis of Xp11.2 translocation (Xp11.2t) renal cell carcinoma (RCC) from a multicenter study and compare them with clear-cell RCC using a propensity score matching analysis. PATIENTS AND METHODS: Between 2004 and 2013, 8384 consecutive patients from 7 institutions who were diagnosed with RCC were reviewed, and the pathologically confirmed Xp11.2t cases were enrolled. The oncological outcomes of Xp11...
April 26, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28545998/a-randomized-phase-ii-study-to-determine-the-effect-of-2-different-doses-of-aflibercept-in-patients-with-metastatic-renal-cell-carcinoma-ecog-acrin-e4805
#4
Roberto Pili, Opeyemi Jegede, Michael A Carducci, Judith Manola, David L Groteluschen, Leonard L Appleman, Glenn Liu, James C Shanks, Shaker R Dakhil, Janice Dutcher, Robert S DiPaola
BACKGROUND: Aflibercept is a recombinantly produced fusion protein that has potent anti-vascular endothelial growth factor (VEGF) activity. We tested whether aflibercept has clinical activity in clear-cell renal cell carcinoma (ccRCC). The recommended phase II dose was 4 mg/kg but several patients (pts) treated at 1 mg/kg showed prolonged progression-free survival. We therefore tested both doses in a parallel group randomized trial. PATIENTS AND METHODS: Eligible pts had histologically confirmed advanced or metastatic ccRCC and previous treatments included exposure to a VEGF receptor tyrosine kinase inhibitor...
April 26, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28545997/factors-associated-with-survival-following-radium-223-treatment-for-metastatic-castration-resistant-prostate-cancer
#5
William W Wong, Eric M Anderson, Homan Mohammadi, Thomas B Daniels, Steve E Schild, Sameer R Keole, C Richard Choo, Katherine S Tzou, Alan H Bryce, Thai H Ho, Fernando J Quevedo, Sujay A Vora
BACKGROUND: Radium-223 ((223)Ra) improves survival in patients with metastatic castration-resistant prostate cancer (mCRPC). This retrospective analysis was performed to better understand its efficacy in routine clinical practice and identify factors associated with survival. MATERIALS AND METHODS: Sixty-four patients with mCRPC who received (223)Ra between 2013 and 2015 were the basis of this retrospective study. Clinical outcomes and patient characteristics were obtained...
April 26, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28533051/features-of-ipsilateral-renal-recurrences-after-partial-nephrectomy-a-proposal-of-a-pathogenetic-classification
#6
Alessandro Antonelli, Maria Furlan, Regina Tardanico, Simona Fisogni, Mario Sodano, Francesca Carobbio, Sandra Belotti, Alberto Cozzoli, Tiziano Zanotelli, Claudio Simeone
BACKGROUND: Poor data are reported on the pathogenesis of ipsilateral relapse (IR) after partial nephrectomy (PN). The objective of this study was to investigate features of IR after PN with the intention to propose a pathogenetic classification. MATERIALS AND METHODS: Retrospective consultation of an institutional database that stores the data of 683 patients submitted to PN since 1993. The clinical, radiological, and follow-up data of the cases submitted to salvage nephrectomy due to an IR were analyzed...
April 26, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28526418/prevalence-of-measurable-disease-in-metastatic-castration-resistant-prostate-cancer
#7
Guru Sonpavde, Ankit Madan, Mary K Baker, Jori E May, Gurudatta Naik, Sejong Bae
BACKGROUND: Because of the low historical prevalence of measurable disease in metastatic castration-resistant prostate cancer (mCRPC), phase II trials have used prostate-specific antigen (PSA) and bone scan changes as primary end points. Frequent whole-body imaging and improved computed tomography technology currently identify measurable disease more frequently, warranting consideration of objective response as a major end point. PATIENTS AND METHODS: Data from reported phase III trials of mCRPC were analyzed...
April 26, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28526417/imaging-of-a-pelvic-textiloma-using-18-f-fdg-pet-ct-in-a-patient-with-a-history-of-prostate-cancer-a-case-report-and-review-of-the-literature
#8
Romain Schollhammer, Henri De Clermont-Gallerande, Philippe Fernandez, Marie Meyer
No abstract text is available yet for this article.
April 26, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28522288/grade-group-underestimation-in-prostate-biopsy-predictive-factors-and-outcomes-in-candidates-for-active-surveillance
#9
François Audenet, François Rozet, Matthieu Resche-Rigon, Rémy Bernard, Alexandre Ingels, Dominique Prapotnich, Rafael Sanchez-Salas, Marc Galiano, Eric Barret, Xavier Cathelineau
OBJECTIVE: We intended to analyze the outcomes and predictive factors for underestimating the prostate cancer (PCa) grade group (GG) from prostate biopsies in a large monocentric cohort of patients treated by minimally invasive radical prostatectomy (RP). MATERIALS AND METHODS: Using a monocentric prospectively maintained database, we included 3062 patients who underwent minimally invasive RP between 2006 and 2013. We explored clinicopathologic features and outcomes associated with a GG upgrade from biopsy to RP...
April 26, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28522287/patterns-of-regional-lymphadenectomy-for-clinically-node-negative-patients-with-penile-carcinoma-analysis-from-the-national-cancer-database-from-1998-to-2012
#10
Juan Chipollini, Dominic H Tang, Pranav Sharma, Adam S Baumgarten, Philippe E Spiess
PURPOSE: Evidence supports upfront regional lymphadenectomy (rND) when primary penile tumors exhibit high-risk features and negative inguinal adenopathy (cN0). We sought to analyze trends in the utilization of early rND as well as assess factors associated with its use and survival outcomes using a nationwide cancer registry database. PATIENT AND METHODS: The National Cancer Database was queried for patients with clinically nonmetastatic penile carcinoma and available nodal status who underwent rND from 1998 to 2012...
April 26, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28511950/benign-m%C3%A3-llerian-inclusions-in-lymphadenectomies-for-renal-cell-carcinoma-a-radiologic-and-pathologic-mimic-of-metastases
#11
Christopher P Dall, David S Sharp, Debra L Zynger
No abstract text is available yet for this article.
April 26, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28506560/a-rare-clinical-entity-in-bladder-cancer-paraneoplastic-cerebellar-degeneration
#12
Hakan Anıl, Kaan Karamık, Mutlu Ateş, Mustafa Yüksel, Yasin Aktaş, İbrahim Erol, Ali Yıldız, Murat Savaş
No abstract text is available yet for this article.
April 26, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28499559/identifying-psychosocial-distress-and-stressors-using-distress-screening-instruments-in-patients-with-localized-and-advanced-penile-cancer
#13
Désirée Louise Dräger, Chris Protzel, Oliver W Hakenberg
BACKGROUND: We examined the effects of treatment on the psychological well-being of patients with localized or advanced penile cancer using screening questionnaires to determine the consecutive need for psychosocial care. Penile cancer is a rare, but highly aggressive, malignancy. The psychological stress of patients with penile cancer arises from the cancer diagnosis per se and the corresponding consequences of treatment. In addition, cancer-specific distress results (eg, fear of metastasis, progression, relapse, death)...
April 21, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28495053/evaluation-of-preoperative-aspartate-transaminase-alanine-transaminase-ratio-as-an-independent-predictive-biomarker-in-patients-with-metastatic-renal-cell-carcinoma-undergoing-cytoreductive-nephrectomy-a%C3%A2-propensity-score-matching-study
#14
Hiroki Ishihara, Tsunenori Kondo, Kazuhiko Yoshida, Kenji Omae, Toshio Takagi, Junpei Iizuka, Kazunari Tanabe
BACKGROUND: The usefulness of the aspartate transaminase (AST)/alanine transaminase (ALT) ratio (De Ritis ratio) as a predictive biomarker for patients with metastatic renal cell carcinoma (mRCC) undergoing cytoreductive nephrectomy (CN) remains unclear. PATIENTS AND METHODS: The data from 118 patients were retrospectively evaluated. The endpoints were cancer-specific survival (CSS) and overall survival (OS) after CN. We compared these according to the AST/ALT ratio before and after 1:1 propensity score matching...
April 20, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28506524/contemporary-incidence-and-cancer-control-outcomes-of-primary-neuroendocrine-prostate-cancer-a-seer-database-analysis
#15
Emanuele Zaffuto, Raisa Pompe, Marc Zanaty, Helen Davis Bondarenko, Sami-Ramzi Leyh-Bannurah, Marco Moschini, Paolo Dell'Oglio, Giorgio Gandaglia, Nicola Fossati, Armando Stabile, Kevin C Zorn, Francesco Montorsi, Alberto Briganti, Pierre I Karakiewicz
INTRODUCTION: Neuroendocrine carcinoma of the prostate (NEPC) is a rare entity. We aimed at providing contemporary data on incidence and survival figures of de-novo NEPC. MATERIALS AND METHODS: Within the Surveillance, Epidemiology, and End Results (SEER) database, we identified 309 individuals with de-novo NEPC diagnosed between 2004 and 2013. We evaluated age-adjusted incidence rates over the study. Kaplan-Meier analyses assessed overall survival (OS) after stratification according to histologic subtype, metastatic status, and treatment...
April 13, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28479282/characteristics-and-associated-factors-of-postoperative-pulmonary-complications-in-patients-undergoing-radical-cystectomy-for-bladder-cancer-a-national-surgical-quality-improvement-program-study
#16
Leilei Xia, Benjamin L Taylor, Thomas J Guzzo
INTRODUCTION: The purpose of this study was to summarize the characteristics and identify associated factors of postoperative pulmonary complications (PPCs) in patients undergoing radical cystectomy (RC). MATERIALS AND METHODS: The National Surgical Quality Improvement Project (NSQIP) database (2005-2014) was used to identify patients who underwent RC for bladder cancer. PPCs were defined as pneumonia, unplanned reintubation, and ventilator support > 48 hours within 30 days of RC...
April 13, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28478885/from-the-uncertainties-to-the-evidence-a-brief-history-of-immunotherapy-as-salvage-therapy-for-advanced-bladder-cancer-through-a-meta-analysis
#17
Andrea Necchi, Daniele Raggi, Patrizia Giannatempo, Guru Sonpavde, Matthew D Galsky, Joaquim Bellmunt, Luigi Mariani, Rosalba Miceli
No abstract text is available yet for this article.
April 13, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28465049/consolidative-radiotherapy-in-metastatic-urothelial-cancer
#18
Sumit Shah, Chiyuan Amy Zhang, Steven Hancock, Alice Fan, Eila Skinner, Sandy Srinivas
BACKGROUND: We report outcomes of a retrospective, single-institution experience with consolidative radiation after chemotherapy in metastatic urothelial cancer (MUC). PATIENTS AND METHODS: From our single-institution database of 2597 patients with urothelial carcinoma treated since 1997, we identified 22 patients with MUC who underwent consolidative radiotherapy after a partial response to chemotherapy with the intent of rendering them disease-free. All patients had undergone primary surgical therapy with either cystectomy or nephroureterectomy...
April 12, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28465048/durable-response-to-immune-checkpoint-blockade-in-a-platinum-refractory-patient-with-nonseminomatous-germ-cell-tumor
#19
Ethan A Chi, Michael T Schweizer
No abstract text is available yet for this article.
April 12, 2017: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/28478884/abiraterone-acetate-for-treatment-of-metastatic-castration-resistant-prostate-cancer-in-chemotherapy-naive-patients-an-italian-analysis-of-patients-satisfaction
#20
Luca Cindolo, Clara Natoli, Cosimo De Nunzio, Michele De Tursi, Maurizio Valeriani, Silvana Giacinti, Salvatore Micali, Mino Rizzo, Giampaolo Bianchi, Eugenio Martorana, Marcello Scarcia, Giuseppe Mario Ludovico, Pierluigi Bove, Anastasia Laudisi, Oscar Selvaggio, Giuseppe Carrieri, Maida Bada, Pietro Castellan, Luca Topazio, Stefano Boccasile, Pasquale Ditonno, Paolo Chiodini, Luigi Schips
INTRODUCTION: Abiraterone acetate (AA) gives a significant improvement in survival for patients with metastatic castration-resistant prostate cancer (mCRPC) before and after chemotherapy and has a favorable effect on patients' health-related quality of life and pain. Only a few studies have investigated patient-reported outcomes (PROs) in AA treatment for mCRPC. The aim of this study was to investigate patients' satisfaction in men affected by mCRPC treated with AA. MATERIALS AND METHODS: This was a retrospective analysis of a database of consecutive chemonaive patients with progressive mCRPC...
April 11, 2017: Clinical Genitourinary Cancer
journal
journal
41208
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"